Merit Medical (NASDAQ: MMSI) director Fred Lampropoulos files Form 4 with no trades

Rhea-AI Filing Summary

MERIT MEDICAL SYSTEMS INC director Fred P. Lampropoulos filed a Form 4 reporting his status as an insider. The summarized data show no reported purchases, sales, exercises, gifts, or other equity transactions in the covered period, and no derivative positions listed.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lampropoulos Fred P.

(Last) (First) (Middle)

1600 WEST MERIT PARKWAY

(Street)

SOUTH JORDAN UTAH 84095

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC [ MMSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

*Note: This 'Exit' Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving in the role as the Company's Executive Chairman, effective as of January 4th, 2026, and therefore is no longer subject to Section 16 reporting.

	/s/ Brian G. Lloyd, Attorney-in-Fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What does this MERIT MEDICAL SYSTEMS INC (MMSI) Form 4 show for Fred P. Lampropoulos?

The Form 4 identifies Fred P. Lampropoulos as a director of MERIT MEDICAL SYSTEMS INC. The summarized data indicate no reported share purchases, sales, option exercises, gifts, or restructurings during the period covered by this filing.

Are there any stock purchases or sales reported for MMSI director Fred P. Lampropoulos?

According to the transaction summary, there are no reported buy or sell transactions for Fred P. Lampropoulos, with buyCount, sellCount, and netBuySellShares all shown as zero for this Form 4 filing.

Does the MMSI Form 4 report any option exercises or derivative activity for Fred P. Lampropoulos?

The filing’s derivative summary is empty and the transaction summary shows exerciseCount at zero and derivativeTransactionCount at zero, meaning no option exercises or other derivative transactions are reported for this period.

Are there any gifts or tax-withholding share dispositions reported for MMSI insider Fred P. Lampropoulos?

The transaction summary lists giftCount and taxWithholdingCount as zero, with giftShares and taxWithholdingShares also at zero, indicating no reported gifts or tax-related share withholdings in this Form 4 data.

Does this MMSI Form 4 show any restructuring of Fred P. Lampropoulos’s holdings?

Restructuring-related metrics in the transaction summary—restructuringCount and restructuringShares—are reported as zero. This indicates no entity transfers or similar restructuring transactions are reflected in the provided Form 4 information.